Kreos Capital

Kreos Capital is a prominent growth debt provider based in London, specializing in flexible financing solutions for high-growth companies across Europe and Israel. As an alternative or complement to traditional equity funding, Kreos offers non-dilutive capital, allowing founders to retain greater ownership while scaling their businesses. Their approach targets companies that have demonstrated strong traction and are often backed by leading venture capital firms.

The firm's investment strategy focuses on a diverse range of sectors, including technology, life sciences, and healthcare. They provide capital for various stages of growth, from expansion and working capital needs to M&A activities. Kreos Capital's deep expertise in debt financing for rapidly expanding companies positions them as a strategic partner, offering tailored solutions that align with the specific financial requirements and growth trajectories of their portfolio companies.

Kreos Capital has a substantial financial capacity, underscored by their successful fundraising efforts. For instance, their latest fund, Kreos Capital VII, closed at €650 million in 2023, which translates to approximately $702 million, demonstrating their continued commitment to the European and Israeli markets. This significant capital pool enables them to support a wide array of companies.

Since its inception, Kreos Capital has established a robust track record, having deployed over €4.7 billion across more than 700 transactions in over 17 countries. They typically provide flexible debt facilities ranging from €2 million to €100 million. In U.S. dollar terms, this means their typical first check sizes range from approximately $2.16 million to $108 million, catering to the diverse funding needs of high-growth ventures.